Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Ernst Holler, MD, of University Hospital Regensberg, Regensberg, Germany, briefly outlines the mechanisms behind GvHD, before describing research currently being undertaken to decrease the risk of this condition developing and improve its management.
GvHD biology: tissue tolerance, the micriobiome & biomarkers
